Growth control of 3T3 fibroblast cell lines established from connexin 43-deficient mice

Molecular Carcinogenesis

Volumn 23, Issue 2, 1998, Pages 121-128

  Yamakage, Kohji ^a   Omori, Yasufumi ^a   Piccoli, Colette ^a   Yamasaki, Hiroshi ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Cell growth control; Connexin 43; Gap junctional intercellular communication; Immortalized cell line

Indexed keywords

CONNEXIN 43;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL COMMUNICATION; CELL GROWTH; CELL STRAIN 3T3; FIBROBLAST; GAP JUNCTION; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL LINE;

3T3 CELLS; ANIMALS; BASE SEQUENCE; BLOOD; CELL COMMUNICATION; CELL DIVISION; CONNEXIN 43; DNA PRIMERS; EMBRYO; FEMALE; GAP JUNCTIONS; IMMUNOHISTOCHEMISTRY; MICE; PREGNANCY;

EID: 0031735573     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199810)23:2<121::AID-MC9>3.0.CO;2-P     Document Type: Article

References (37)

1. Bennett MV, Barrio LC, Bargiello TA, Spray DC, Hertzberg E, Saez JC. Gap junctions: New tools, new answers, new questions. Neuron 6:305-320, 1991.
2. Verselis V, Brink PR. The gap junction channel. Its aqueous nature as indicated by deuterium oxide effects. Biophys J 50:1003-1007, 1986.
3. Goodenough DA, Goliger JA, Paul DL. Connexins, connexons, and intercellular communication. Annu Rev Biochem 65:475-502, 1996.
4. Bruzzone R, White TW, Paul DL. Connections with connexins: The molecular basis of direct intercellular signaling. Eur J Biochem 238:1-27, 1996.
5. Bergoffen J, Scherer SS, Wang S, et al. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 262:2039-2042, 1993.
6. Kelsell DP, Dunlop J, Stevens HP, et al. Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature 387:80-83, 1997.
7. Britz-Cunningham SH, Shah MM, Zuppan CW, Fletcher WH. Mutations of the Connexin43 gap-junction gene in patients with heart malformations and defects of laterality. N Engl J Med 332:1323-1329, 1995.
8. Reaume AG, de Sousa PA, Kulkarni S, et al. Cardiac malformation in neonatal mice lacking connexin43. Science 267:1831-1834, 1995.
9. Gong X, Li E, Klier G, et al. Disruption of alpha3 connexin gene leads to proteolysis and cataractogenesis in mice. Cell 91:833-843, 1997.
10. Simon AM, Goodenough DA, Li E, Paul DL. Female infertility in mice lacking connexin 37. Nature 385:525-529, 1997.
11. Loewenstein WR, Kanno Y. Intercellular communication and the control of tissue growth: Lack of communication between cancer cells. Nature 209:1248-1249, 1966.
12. Yamasaki H, Naus CC. Role of connexin genes in growth control. Carcinogenesis 17:1199-1213, 1996.
13. Rivedal E, Yamasaki H, Sanner T. Inhibition of gap junctional intercellular communication in Syrian hamster embryo cells by TPA, retinoic acid and DDT. Carcinogenesis 15:689-694, 1994.
14. Baker TK, Kwiatkowski AP, Madhukar BV, Klaunig JE. Inhibition of gap junctional intercellular communication by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rat hepatocytes. Carcinogenesis 16:2321-2326, 1995.
15. Krutovskikh VA, Mesnil M, Mazzoleni G, Yamasaki H. Inhibition of rat liver gap junction intercellular communication by tumor-promoting agents in vivo. Association with aberrant localization of connexin proteins. Lab Invest 72:571-577, 1995.
16. Kamibayashi Y, Oyamada Y, Mori M, Oyamada M. Aberrant expression of gap junction proteins (connexins) is associated with tumor progression during multistage mouse skin carcinogenesis in vivo. Carcinogenesis 16:1287-1297, 1995.
17. Budunova IV, Carbajal S, Slaga TJ. The expression of gap junctional proteins during different stages of mouse skin carcinogenesis. Carcinogenesis 16:2717-2724, 1995.
18. Kalimi GH, Sirsat SM. The relevance of gap junctions to stage I tumor promotion in mouse epidermis. Carcinogenesis 5:1671-1677, 1984.
19. Kalimi GH, Sirsat SM. Phorbol ester tumor promoter affects the mouse epidermal gap junctions. Cancer Lett 22:343-350, 1984.
20. Enomoto T, Yamasaki H. Lack of intercellular communication between chemically transformed and surrounding nontransformed BALB/c 3T3 cells. Cancer Res 44:5200-5203, 1984.
21. Azarnia R, Reddy S, Kmiecik TE, Shalloway D, Loewenstein WR. The cellular src gene product regulates junctional cell-to-cell communication. Science 239:398-401, 1988.
22. Bignami M, Rosa S, Falcone G, Tato F, Katoh F, Yamasaki H. Specific viral oncogenes cause differential effects on cell-to-cell communication, relevant to the suppression of the transformed phenotype by normal cells. Mol Carcinog 1:67-75, 1988.
23. Kalimi GH, Hampton LL, Trosko JE, Thorgeirsson SS, Huggett AC. Homologous and heterologous gap-junctional intercellular communication in v-raf-, v-myc-, and v-raf/v-myc-transduced rat liver epithelial cell lines. Mol Carcinog 5:301-310, 1992.
24. Eghbali B, Kessler JA, Reid LM, Roy C, Spray DC. Involvement of gap junctions in tumorigenesis: Transfection of tumor cells with connexin 32 cDNA retards growth in vivo. Proc Natl Acad Sci USA 88:10701-10705, 1991.
25. Rose B, Mehta PP, Loewenstein WR. Gap-junction protein gene suppresses tumorigenicity. Carcinogenesis 14:1073-1075, 1993.
26. Mesnil M, Krutovskikh V, Piccoli C, et al. Negative growth control of HeLa cells by connexin genes: Connexin species specificity. Cancer Res 55:629-639, 1995.
27. Goldberg GS, Martyn KD, Lau AF. A connexin 43 antisense vector reduces the ability of normal cells to inhibit the foci formation of transformed cells. Mol Carcinog 11:106-114, 1994.
28. Yamasaki H, Katoh F. Further evidence for the involvement of gap-junctional intercellular communication in induction and maintenance of transformed foci in BALB/c 3T3 cells Cancer Res 48:3490-3495, 1988.
29. Esinduy CB, Chang CC, Trosko JE, Ruch RJ. In vitro growth inhibition of neoplastically transformed cells by non-transformed cells: Requirement for gap junctional intercellular communication. Carcinogenesis 16:915-921, 1995.
30. Aaronson SA, Todaro GJ. Development of 3T3-like lines from Balb-c mouse embryo cultures: Transformation susceptibility to SV40. J Cell Physiol 2:141-148, 1968.
31. Omori Y, Mesnil M, Yamasaki H. Connexin 32 mutations from X-linked Charcot-Marie-Tooth disease patients: Functional defects and dominant negative effects. Mol Biol Cell 6:907-916, 1996.
32. Blasco MA, Lee HW, Hande MP, et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91:25-34, 1997.
33. Martyn KD, Kurata WE, Warn-Cramer BJ, Burt JM, TenBroek E, Lau AF. Immortalized connexin43 knockout cell lines display a subset of biological properties associated with the transformed phenotype. Cell Growth Differ 9:1015-1027, 1997.
34. Musil LS, Cunningham BA, Edelman GM, Goodenough DA. Differential phosphorylation of the gap junction protein connexin43 in junctional communication-competent and -deficient cell lines. J Cell Biol 5:2077-2088, 1990.
35. Guan X, Wilson S, Schlender KK, Ruch RJ. Gap-junction disassembly and connexin 43 dephosphorylation induced by 18 beta-glycyrrhetinic acid. Mol Carcinog Sb 16:157-164, 1996.
36. de Feijter AW, Matesic DF, Ruch RJ, Guan X, Chang CC, Trosko JE. Localization and function of the connexin 43 gap-junction protein in normal and various oncogene-expressing rat liver epithelial cells. Mol Carcinog Sb 16:203-212, 1996.
37. Naus CC, Bechberger JF, Zhang Y, et al. Altered gap functional communication, intercellular signaling, and growth in cultured astrocytes deficient in connexin43. J Neurosci Res 49:528-540, 1997.